TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Investor Notice: Robbins LLP Informs Investors of the Telix Pharmaceuticals Ltd. Securities Class Action

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Robbins Llp
Investor Notice: Robbins LLP Informs Investors of the Telix Pharmaceuticals Ltd.  Securities Class Action

A class action lawsuit has been filed against Telix Pharmaceuticals for allegedly misleading investors about its prostate cancer therapeutic candidates and manufacturing processes, following an SEC investigation and FDA Complete Response Letter.

Insights
TLX   negative

The company received an SEC investigation, a Complete Response Letter from FDA citing manufacturing deficiencies, and experienced a stock price decline due to disclosed issues with its prostate cancer therapeutic candidates and supply chain